Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.70 |
| ▸ | CA9 | Q16790 | 7/20 | 0.70 |
| ▸ | CA1 | P00915 | 6/20 | 0.70 |
| ▸ | STS | P08842 | 7/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9451233 | 0.98 | CA2 (0.73) | CA2CA9CA1STSCA12 | |
| SCHEMBL30872943 | 0.96 | CA2 (0.70) | CA2CA9CA1STSCA12 | |
| SCHEMBL9451263 | 0.83 | CA2 (1.00) | CA2CA9CA1STS | |
| SCHEMBL4431267 | 0.82 | CA1 (0.45) | CA2CA9CA1STSCA12 | |
| Hydrazine SCHEMBL28045004 | 0.81 | CA1 (0.48) | CA2CA9CA1STSCA12 | |
| SCHEMBL10558186 | 0.80 | CA1 (0.47) | CA2CA9CA1CA12 | |
| SCHEMBL17688536 | 0.78 | NFE2L2 (0.51) | CA2CA9CA1 | |
| SCHEMBL17681373 | 0.78 | CA1 (0.45) | CA2CA9CA1 | |
| SCHEMBL29508627 | 0.78 | NFE2L2 (0.51) | CA2CA9CA1 | |
| SCHEMBL9451543 | 0.77 | CA2 (0.61) | CA2CA9CA1STSCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | CA2 3201/4885CA9 1611/4885CA1 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.